Healthcare -
Biotechnology - NASDAQ - US
$ 4.58
-2.14 %
$ 212 M
Market Cap
-1.61
P/E
FDMT - NET CHANGE IN CASH
Net Change in Cash FDMT - 4D Molecular Therapeutics, Inc.
197 M
LAST VALUE
89.48%
2 YEAR CAGR
23.71%
5 YEAR CAGR
0.00%
10 YEAR CAGR